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Cronobacter sakazakii is a neonatal pathogen responsible for up to 80% of fatalities in infected infants. Low birth
weight infants and neonates infected with C. sakazakii suffer necrotizing enterocolitis, bacteraemia and meningitis. The
mode of transmission most often associated with infection is powdered infant formula (PIF) which, with an aw of »0.2,
is too low to allow most microorganisms to persist. Survival of C. sakazakii in environments subject to extreme
hyperosmotic stress has previously been attributed to the uptake of compatible solutes including proline and betaine.
Herein, we report the construction and screening of a C. sakazakii genome bank and the identiﬁcation of ProP
(ESA_02131) as a carnitine uptake system.
Introduction
The neonatal pathogen Cronobacter sakazakii is a Gram nega-
tive, rod shaped, motile, non-spore-forming, facultatively anaero-
bic bacterium belonging to the Enterobacteriaceae family.1
C. sakazakii is associated with neonatal infections and can cause
bacteraemia and sepsis, cerebro-spinal and peritoneal fluid accu-
mulation, brain abscesses, cyst formation, necrotizing enterocoli-
tis (NEC), meningitis and intracerebral infarctions.2 While
C. sakazakii is ubiquitous in the environment,3,4 the ability of
the organism to survive in extremely low water environments is a
unique stress survival strategy which has significantly raised the
profile of this foodborne pathogen in recent years.5
Survival of C. sakazakii for extended periods in powdered
infant formula has been observed, with some capsulated strains
surviving for up to 2.5 years.6 Indeed, a 2004 study found that
8 out of 9 PIF factories investigated were contaminated with
C. sakazakii.7 Given that pasteurisation effectively inactivates
C. sakazakii, the presence of the pathogen in powdered infant
formula is attributed mainly to post-processing environmental
contamination, such as the addition of contaminated ingredients
and/or the use of non-sterile equipment.8 Previous studies also
suggest that reformulation; specifically the addition of non-
essential substitutes, such as carnitine and proline, may act as
protective compounds, facilitating increased survival of
C. sakazakii and other osmotolerant pathogens in PIF.9-11
The global standard for the composition of infant formula12
lists the compositional requirements proposed by The Codex Ali-
mentarius Commission of Food and Agriculture Organization of
the United Nations and the World Health Organization. This
standard states that other ingredients may be added to ensure
that the infant formula is adequate as the sole source of nutrition
or to provide other benefits that are comparable with breastfed
babies. In particular protein is recognized as an essential nutri-
tional requirement and the global standards suggest a minimum
guideline of 1.8 g/100 kcal for cow’s milk protein and hydro-
lysed cow’s milk protein and 2.25 g/100 kcal for Soy protein iso-
lates. Formula is also supplemented with a large variety of amino
acids to provide a more nutritionally complete and balanced
food source.12 Examples of free amino acids include carnitine,
tyrosine, cysteine and taurine. Carnitine is proposed as a compo-
sitional requirement in infant formula by the FAO/WHO,
wherein a minimum quantity of 1.2 mg/100 kcal is proposed
with no maximum quantity specified. A previous study, carried
out by the Scientific Committee on Food and the Life Sciences
Research Office of the American Society for Nutritional Sciences,
proposed a maximum level of 2 mg/100 kcal, based on the usual
range found in human milk, in the absence of indications of any
untoward effects of higher L-carnitine intake in infants.13 By
contrast, the International Expert Group concluded that no max-
imum level is required.12 Carnitine is therefore present in many
brands of powdered infant formula at varying levels.
Carnitine is most commonly found in foods of animal ori-
gin.14,15 In prokaryotes carnitine has been identified as an
important osmoprotectant; allowing the cell to overcome signifi-
cant increases in osmolality.16,17 In particular, carnitine has
been identified as an essential osmoprotectant in the foodborne
pathogen L. monocytogenes and has been shown to play a signifi-
cant role in pathogenesis.18,19 Smith20 demonstrated that 1 mM
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carnitine results in an approximate doubling of the growth rate
of L. monocytogenes at 4% NaCl.21 Cells grown in defined and
complex media demonstrate a high rate of carnitine uptake,
suggesting that the listerial carnitine transport system is consti-
tutively expressed rather than induced by a high ionic or non-
ionic solute concentration.22 Furthermore, carnitine uptake in
L. monocytogenes is ATP-driven and varies depending on the
growth phase of the cell and the availability of other osmolytes
such as betaine or proline.14 The principal carnitine uptake sys-
tem in L. monocytogenes is encoded by the opuC operon which
encodes an ATP binding protein (OpuCA), an extracellular sub-
strate binding protein (OpuCC) and 2 membrane associated
proteins (OpuCB and OpuCD).18 This ATP-binding transport
system has also been demonstrated to transport proline and gly-
cine betaine, further highlighting the importance of this com-
patible solute in cellular osmoregulation.
Recent in silico analysis of the C. sakazakii genome identified
2 copies of opuC,5 suggesting that C. sakazakii may indeed utilize
carnitine in a similar way to L. monocytegenes. In the same study
we identified 7 copies of the ProP homolog, originally annotated
as a proline uptake system, and suggest that these ProP homo-
logues are the primary drivers of C. sakazakii osmotolerance.23
Furthermore, as has been previously reported in other bacteria,24
we suggest that the presence of a C-terminal coiled coil domain
of one of the ProP homologues (ESA_02131) is essential for
optimal transporter activity.25
Herein, we describe a functional genomic screen of
C. sakazakii BAA-894; revealing a novel role for the ProP homo-
log (ESA_02131) as a carnitine uptake system. Indeed, carnitine
uptake via ProP allows growth of the pathogen at salt concentra-
tions far in excess of that afforded by proline; a finding which has
significant food safety implications, given that carnitine is often
added to infant formula to boost its nutritional benefit.26
Material and Methods
Media, chemicals and growth conditions
Bacterial strains and plasmids used in this study are listed in
Table 1. Escherichia coli strains were grown at 37C in either
Luria-Bertani (LB) medium or M9 minimal media27 containing
0.5% glucose, 0.04% arginine, 0.04% isoleucine, 0.04% valine
(Sigma-Aldrich Co.) to support the growth of E. coli MKH13.28
Cronobacter sakazakii was grown in either LB or chemically
defined media. Carnitine was filter sterilised and added to M9
minimal media to a final concentration of 1 mM (Sigma-Aldrich
Co.). Ampicillin was made up as a concentrated stock solution
(100 mg/ml) and added to media at the required levels. Electro-
transformed cells were recovered using SOC media prepared as
described by Sleator et al.29 Osmolality of the defined and com-
plex media was adjusted by the addition of NaCl. All strains were
grown at 37C with shaking at 200 rpm, unless otherwise stated.
Where solid media was required, agar was added at 1.5%.
DNA manipulations and sequence analysis
Restriction enzymes, RNase, shrimp alkaline phosphatase and
T4 DNA ligase were obtained from Roche Diagnostics and used
according to the manufacturers’ instructions. Bacterial genomic
DNA was isolated as described previously.30 Plasmid DNA was
isolated using the High Pure Plasmid Isolation kit (Roche Diag-
nostics). PCR reactions were carried out using the high fidelity
Velocity DNA polymerase Kit (Bioline) in accordance with man-
ufacturers’ instructions. PCR products were purified using the
Roche plasmid purification kit (Roche Diagnostics). Oligonucle-
otide primers (listed in Table 2) used for PCR and sequence
analysis were synthesized by MWG (MWG Operon, Germany
and GATC, Germany). Nucleotide analysis was performed using
the SimplicityTM platform31 (nSilico Ltd., Cork, Ireland). Elec-
trocompetent E. coli DH5a, obtained from New England Biol-
abs and E. coli MKH13 were made electrocompetent using the
method outlined by Sambrook et al.27 Electrotransformation was
carried out using standard protocols.
Creation of C. sakazakii BAA-894 genome bank
A DNA library, consisting of C. sakazakii BAA-894 genomic
DNA, was created by partially digesting the genomic DNA with
Sau3A to yield genomic fragments, ranging in size from 300 bp
to 3000 bp. The pUC18 plasmid was digested with BamH1 and
dephosphoylated with shrimp alkaline phosphatase. The genomic
fragments were ligated to the digested plasmid using T4 DNA
ligase (Roche). The resulting recombinant plasmids were then
purified and transformed into restriction-deficient E. coli DH5a.
LB plates containing ampicillin (50 mg/ml), IPTG (isopropyl-1-
thio-b-D-galactopyranoside) (1 mM), and X-Gal (5-bromo-4-
Table 1. Bacterial strains and plasmids
Strain or Plasmid Relevant Genotype or Characteristics Source or Reference
Plasmids
pUC18 Ampr, lacZ’, pMB9 replicon 40
pUC18::BAA894 pUC18 containing 300–3000bp fragment from C. sakazakii genome This study
Strains
Cronobacter sakazakii BAA-894 C. sakazakii strain isolated from powdered formula associated with neonatal intensive care unit 41
Escherichia coli DH5a Intermediate cloning host.supE44 DlacU169(80lacZDM15)R17 recA1 endA1 gyrA96 thi-1 relA1. Invitrogen
E. coli MKH13 MC4100D(putPA)101D(proP)2D(proU) 42
E. coli MKH13::pUC18 Host strain harbouring the empty pUC18 plasmid. Ampr This study
E. coli MKH13::ProP (ESA_02131) Host strain harbouring pUC18 containing ProP (ESA_02131) from the C. sakazakii genome. Ampr This study
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chloro-3-indolyl-b-D-galactopyranoside) (40 mg/ml) were used
for blue/white screening as outlined by Sambrook et al.27 Com-
plemented plasmids were isolated from E. coli DH5a and puri-
fied prior to electrotransformation into the osmotically sensitive
E. coli MKH13 strain. E. coli MKH13 strains expressing the
plasmid were selected on media containing ampicillian. Growth
on high osmolality media containing added carnitine, followed
by PCR of transformants and subsequent sequencing, confirmed
successful transformation. Transformants were pooled and
stocked at ¡80C.
Osmotolerance assay
The genome bank was screened on defined media containing
1 mM carnitine in the presence of NaCl (>4%) for positive
selection of osmotolerant clones. Overnight cultures of E. coli
MKH13 clones possessing a putative osmotolerance gene of
interest were grown at 37C with shaking at 200 rev min¡1 in
10 ml M9 minimal media containing 0.5% glucose, 0.04% argi-
nine, 0.04% isoleucine, 0.04% valine (Sigma-Aldrich Co.). Cells
were centrifuged at 5,000 g, before being washed and re-sus-
pended in 1/4 strength Ringer’s solution. The cell suspension
(200 ul) was added to 1800 ul of defined growth media contain-
ing carnitine and varying concentrations of NaCl (0–10%).
Optical density (OD600) readings were taken every hour, over a
48 hour period. Readings were taken in triplicate and graphs
were constructed using SigmaPlot version 11.0.
Results and Discussion
A C. sakazakii BAA-894 genome bank was created using
a random shot gun approach, with partial Sau3A digestion.
Genome fragments of various sizes (300–3000 bp) were cloned
into the E. coli DH5a, a restriction deficient intermediary clon-
ing host, followed by MKH13, an osmosensitive secondary host,
for further phenotypic characterization. Following transforma-
tion of the pUC18::BAA-894 genome bank into MKH13, suc-
cessful transformants were selected on minimal medium
containing 4% added NaCl and 1 mM carnitine. No colonies
appeared following a control transformation with the empty vec-
tor (pUC18 alone), while transformation efficiencies of approxi-
mately 70 CFU/mg of DNA were achieved from the plasmid
bank, with colonies appearing after 36 h at 37C. Plasmid
DNA isolated from a representative colony was retransformed
into MKH13 to confirm complementation. Sequence analysis
revealed the cloned insert to be ProP (ESA_02131)
E. coli MKH13 harbouring ProP (ESA_02131) was grown in
minimal media containing 0–10% NaCl and 1 mM carnitine.
Growth was monitored each hour over a 48 hour period at an
optical density of 600 nm. The transformed cells demonstrated
significant osmotolerance, with carnitine as the only compatible
solute present, while the control E. coli MKH13::pUC18 strain
showed little or no grow above 4% NaCl. Notably, E. coli
MKH13 expressing ProP (ESA_02131) grew to an OD of 0.55
in media containing 10% NaCl (Fig. 1). Previous work in our
lab demonstrated that ProP (ESA_02131) encodes a proline/gly-
cine betaine uptake system.32 However, this is the first study to
show that the membrane bound transporter also functions as a
carnitine uptake system. Furthermore, the growth kinetics
recorded in the presence of carnitine are significantly higher than
those observed when proline was supplied as the sole compatible
solute. E. coli MKH13 transformed with ProP (ESA_02131)
reached an optical density of 0.25 at 9% NaCl with 1 mM pro-
line, compared to 0.57 at the equivalent salt concentration with
1 mM carnitine.
Kets et al.33 was one of the first to report on the osmoprotec-
tive effects of carnitine in bacteria; showing increased growth of
Lactobacillus plantarum in media containing between 0.5–1 M
NaCl. Beumer et al.34 also described the osmoprotective effective
of carnitine on L. monocytogenes grown at elevated osmolarities.
Carnitine has since been identified as playing a central role in
bacterial osmoprotection, transported from the external environ-
ment rather than being synthesized endogenously.35 The opuC
operon, 2 copies of which were previously identified on the
C. sakazakii BAA-894 genome,5 encodes a carnitine transporter
found in many Gram positives, including Bacillus subtilis and
L. monocytogenes. However, in addition to carnitine, OpuC has
Figure 1. Growth of E. coli MKH13::ProP (ESA_02131), triangles and E. coli
MKH13::pUC18, circles, in M9 minimal media with 1 mM carnitine and
10% NaCl.
Table 2. Primers
Primer name Primer sequence (50 to 30) Length Characteristics
pUC18 MCS Check F CATTAGCTCACTCATTAGGCACC 23 pUC18 insert check
R CATTGTAAAACGACGGCCAGTG 22 pUC18 insert check
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also been shown to transport other compatible solutes such as
ectoine, crotonobetaine, choline, proline betaine and glycine beta-
ine.
Likewise the ProP transporter of E. coli, although originally iden-
tified as a proline porter, also exhibits carnitine uptake at Km and
Vmax values of 200–250 uM and 1.2 nmol min¡1, respec-
tively.36 The results obtained in the present study demonstrate
that ProP (ESA_02131) likely plays a similar role to its homolog
in E. coli; facilitating the uptake of carnitine as well as proline
and glycine betaine. Indeed, the greater osmotic protection
afforded to C. sakazakii by carnitine, versus proline, would sug-
gest that ProP might be more appropriately regarded as a carni-
tine uptake system, rather than simply a proline porter, in
C. sakazakii. Indeed, we failed to link either of the 2 OpuC
homologues (ESA_01738–01741 and ESA_01108–ESA_01111)
to carnitine uptake, using the functional screen described in the
current study; though this might simply be due to limitations of
the existing bank.
The use and concentration of carnitine in PIF is diverse;
varying widely between manufacturers. In 2003 the Scientific
Committee on Food approved L-carntine as a nutrient for
inclusion in infant formulae based on soy protein and hydro-
lysed protein but did not consider it necessary to add L-carni-
tine to cows’ milk-based formula.37 However, many brands of
PIF continue to add carnitine as a non-essential supplement.
The specific function of carnitine in PIF is as a nutrient supple-
ment. Carnitine is a quaternary amine which is required for the
transport of long chain fatty acids across the mitochondrial
membrane to be oxidised for energy at the target tissue or for
storage as a triglycerol.38 However, the results of this study
demonstrate that C. sakazakii, like many other osmotolerant
pathogens, can utilize carnitine as a compatible solute to aid
survival in this dry environment. Thus, while carnitine may be
a beneficial nutritional supplement in PIF, its use also contrib-
utes to survival of pathogens such as C. sakazakii, with mortality
rates of up to 80% in infected infants.
Conclusion and Future Prospects
The Irish dairy industry produces approximately 15% of
the entire global exports of infant milk formula and is there-
fore a major contributor to the global PIF industry. Much
of the PIF produced in Ireland contains carnitine as a nutri-
ent supplement. While the nutritional benefits of carnitine
are important for healthy growth and development of the
infant,38 the presence of carnitine in PIF may also facilitate
the survival of the neonatal pathogen C. sakazakii. This
study demonstrated that ProP (ESA_02131), previously iden-
tified as a proline/glycine betaine transporter,32 can be fur-
ther characterized as a carnitine uptake system. Furthermore,
carnitine appears to have a greater osmoprotective effect than
proline when accumulated via ProP (ESA_02131). Thus,
while reversing the policy of adding carnitine to infant for-
mula, to boost its nutritional value, is an obvious first step
in reducing the burden of C. sakazakii, ProP (ESA_02131)
itself is also an obvious target for the control of the patho-
gen. This approach involves smugglin technology; the use of
antimicrobial compounds which structurally mimic carnitine,
killing the cell rather than protecting it. This represents a
viable alternative to antibiotic therapy and may lead to effec-
tive control of the pathogen in high risk foods such as
PIF.10,39
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